Inogen Sees FY23 Revenue $315M-$320M Vs $317.11M Est.
Portfolio Pulse from Benzinga Newsdesk
Inogen has provided its financial guidance for FY23, expecting revenue of $315 million to $320 million. The company also anticipates an Adjusted EBITDA loss of approximately $27 million for the full year, including investments in the Simeox airway clearance portfolio.
November 08, 2023 | 12:48 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Inogen's FY23 revenue guidance is in line with estimates, but the company expects a significant Adjusted EBITDA loss due to investments in its Simeox airway clearance portfolio.
Inogen's revenue guidance for FY23 is within the estimated range, which is a positive sign. However, the expected EBITDA loss, largely due to investments in the Simeox airway clearance portfolio, could be a concern for investors. This could potentially offset any positive sentiment from the revenue guidance, leading to a neutral short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100